Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07781631
PHASE1

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.

Official title: An Open-label, Fixed-sequence, Two-period Phase I Trial to Evaluate the Effect of Multiple Oral Doses of Carbamazepine, a Strong CYP3A4 Inducer, on the Pharmacokinetics of Verducatib at Steady State in Healthy Male Trial Participants

Key Details

Gender

MALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-09-10

Completion Date

2026-12-20

Last Updated

2026-09-23

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Verducatib

Verducatib

DRUG

Carbamazepine

Carbamazepine

Locations (1)

CRS Clinical Research Services Berlin GmbH

Berlin, Germany